Steward Partners Investment Advisory, LLC Xilio Therapeutics, Inc. Transaction History
Steward Partners Investment Advisory, LLC
- $10.9 Billion
- Q1 2025
A detailed history of Steward Partners Investment Advisory, LLC transactions in Xilio Therapeutics, Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 20,000 shares of XLO stock, worth $17,600. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,000
Previous 20,000
-0.0%
Holding current value
$17,600
Previous $19,000
26.32%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding XLO
# of Institutions
32Shares Held
11MCall Options Held
0Put Options Held
0-
Bain Capital Life Sciences Investors, LLC Boston, MA4.57MShares$4.02 Million1.1% of portfolio
-
River Vest Venture Management LLC St. Louis, MO1.44MShares$1.27 Million16.6% of portfolio
-
Morgan Stanley New York, NY1.16MShares$1.02 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.14MShares$999,4300.0% of portfolio
-
Aju Ib Investment Co., Ltd. Seoul, M5668KShares$587,6120.57% of portfolio
About Xilio Therapeutics, Inc.
- Ticker XLO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,471,600
- Market Cap $24.2M
- Description
- Xilio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies to improve the immune system of cancer patients. Its checkpoint inhibitor program includes XTX101, a clinical-stage, tumor-selective anti-CTLA-4 mAb that is in Phase 1/2 clinical trials in patients with solid tumors. The company also develops cytokine prog...